Business Context and Reporting Period
Company: Boston Scientific Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 18, 2026
Event: Announcement of an Accelerated Share Repurchase (ASR) agreement.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. It focuses exclusively on capital allocation activities.
- ASR Program Size: $2 billion
- Initial Share Delivery: Approximately 30.4 million shares
- Valuation Basis: 80% of the repurchase price based on the May 15, 2026 closing price of $52.68
- Remaining Repurchase Authorization: $3 billion (from a total $5 billion authorization)
- Counterparty: JPMorgan Chase Bank, National Association
Material Changes
The filing details a material change in the company's capital structure and share count due to the initiation of the ASR program. The company has committed $2 billion of its authorized capital to repurchase shares, reducing the remaining available authorization to $3 billion.
Guidance, Outlook, and Risks
Settlement Timeline: Final settlement of the ASR is expected by June 30, 2026. The final share count will be determined by the volume-weighted average price during the term, less a discount.
Forward-Looking Statements: The filing includes standard disclaimers regarding uncertainties in business strategy, product performance, and market conditions.
Risk Factors: Potential variances in actual results are attributed to economic conditions, foreign currency fluctuations, regulatory changes, geopolitical events, supply chain disruptions, cybersecurity risks, and clinical trial outcomes.
Investor Verification Checklist
- Verify the final number of shares repurchased upon settlement in late June 2026.
- Confirm the impact of the $2 billion cash outflow on the company's liquidity position in the next quarterly report (10-Q).
- Monitor the remaining $3 billion share repurchase authorization for future utilization.
- Review the press release (Exhibit 99.1) for any additional strategic commentary not included in the 8-K text.